At each stage of our work we use guidelines from regulatory agencies (EMA, FDA), literature data, as well as modern approaches to experimental planning and data analysis, such as QbD (Quality by Design) or DoE (Design of Experiment).
The use of statistical software (including JMP and GraphPad) allows for reliable inferences based not only on observations but also on numerical data. A broad perspective on each project allows us to achieve success quickly and efficiently. We consult research plans with top class experts in biopharmaceutical and regulatory affairs.